Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 8/2017

Inhalt (15 Artikel)

Focussed Research Review

Schwann cells: a new player in the tumor microenvironment

Yuri L. Bunimovich, Anton A. Keskinov, Galina V. Shurin, Michael R. Shurin

Focussed Research Review

Dendritic cell rehab: new strategies to unleash therapeutic immunity in ovarian cancer

Chang-Suk Chae, Eli Teran-Cabanillas, Juan R. Cubillos-Ruiz

Focussed Research Review

Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease

Colleen S. Netherby, Scott I. Abrams

Focussed Research Review

Bone marrow myeloid cells in regulation of multiple myeloma progression

Sarah E. Herlihy, Cindy Lin, Yulia Nefedova

Focussed Research Review

CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma

Viktor Umansky, Carolin Blattner, Christoffer Gebhardt, Jochen Utikal

Focussed Research Review

Tumor-associated myeloid cells as guiding forces of cancer cell stemness

Antonio Sica, Chiara Porta, Alberto Amadori, Anna Pastò

Focussed Research Review

Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy

Hong Jiang, Samarth Hegde, David G. DeNardo

Focussed Research Review

IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment

David H. Munn, Madhav D. Sharma, Theodore S. Johnson, Paulo Rodriguez

Focussed Research Review

Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments

Sabina Sangaletti, Claudia Chiodoni, Claudio Tripodo, Mario P. Colombo

Focussed Research Review

LILRB receptor-mediated regulation of myeloid cell maturation and function

William van der Touw, Hui-Ming Chen, Ping-Ying Pan, Shu-Hsia Chen

Focussed Research Review

Regulatory myeloid cells: an underexplored continent in B-cell lymphomas

Mikael Roussel, Jonathan M. Irish, Cedric Menard, Faustine Lhomme, Karin Tarte, Thierry Fest

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.